| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 9 |
| 1 | BORTEZOMIB | 9 |
| 2 | DEXAMETHASONE | 8 |
| 3 | DEXAMETHASONE 1.5 MG | 8 |
| 4 | CYCLOPHOSPHAMIDE | 7 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 7 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 7 |
| 7 | DARATUMUMAB | 7 |
| 8 | ESOMEPRAZOLE MAGNESIUM | 7 |
| 9 | PREDNISOLONE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ISRADIPINE | 3 | 0.0054 |
| 1 | ELRANATAMAB-BCMM | 3 | 0.0026 |
| 2 | ECHINACEA (ANGUSTIFOLIA), TABEBUIA IMPETIGINOSA, HYDRASTIS CANADENSIS, GLANDULA SUPRARENALIS SUIS, THYMUS (SUIS), THYROIDINUM (SUIS), ARSENICUM ALBUM, BRYONIA (ALBA), COCCULUS INDICUS, COLCHICUM AUTUMNALE, LEDUM PALUSTRE, MERCURIUS CYANATUS, NATRUM SULPHURICUM, PULSATILLA (PRATENSIS), SEPIA, SILICEA, AFLATOXIN (B1) | 1 | 0.0014 |
| 3 | IDARUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| 4 | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | 1 | 0.0008 |
| 5 | VERTEPORFIN FOR INJECTION | 1 | 0.0007 |
| 6 | VINBLASTINE SULFATE | 1 | 0.0005 |
| 7 | TREMELIMUMAB | 2 | 0.0005 |
| 8 | TECLISTAMAB-CQYV | 1 | 0.0004 |
| 9 | IDELALISIB | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 9 | 0.0015 |
| 1 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 2 | Photoenhancer [EPC] | 1 | 0.0003 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 5 | 0.0001 |
| 4 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 5 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 6 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 8 | Proteasome Inhibitor [EPC] | 10 | 0.0001 |
| 9 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |